Prof. Luc Stoppini received his Ph.D. degree in
neurobiology. Since 2008, he has been a professor of bio-engineering with the
University of Applied Sciences Western Switzerland Geneva, Geneva, Switzerland.
Previously, he was the R&D Director of Capsant Neurotechnologies Ltd. U.K.,
and the Founder and President of BioCell-Interface S.A, Switzerland. He has
held academic positions with the Universities of Lyon, Lyon, France, Geneva, and
Virginia (UVA, Charlottesville). He was involved in commercializing
technologies for the last ten years. Prior to joining Capsant Ltd, he was
developing in vitro models of neurodegenerative diseases (multiple sclerosis)
within the Serono's research center based in Geneva. He set up in vitro
models to study physiological and patho-physiological processes occurring in
the central nervous system. He was the pioneer in developing the technique of
brain organotypic slice cultures on membranes, which is currently used in
numerous public institutions as well as private companies. In parallel to his
activities on biological tissues, he was involved in the development and validation of different types of bio-electronic interfaces.
Prof. Luc Stoppini received his Ph.D. degree in
neurobiology. Since 2008, he has been a professor of bio-engineering with the
University of Applied Sciences Western Switzerland Geneva, Geneva, Switzerland.
Previously, he was the R&D Director of Capsant Neurotechnologies Ltd. U.K.,
and the Founder and President of BioCell-Interface S.A, Switzerland. He has
held academic positions with the Universities of Lyon, Lyon, France, Geneva, and
Virginia (UVA, Charlottesville). He was involved in commercializing
technologies for the last ten years. Prior to joining Capsant Ltd, he was
developing in vitro models of neurodegenerative diseases (multiple sclerosis)
within the Serono's research center based in Geneva. He set up in vitro
models to study physiological and patho-physiological processes occurring in
the central nervous system. He was the pioneer in developing the technique of
brain organotypic slice cultures on membranes, which is currently used in
numerous public institutions as well as private companies. In parallel to his
activities on biological tissues, he was involved in the development and validation of different types of bio-electronic interfaces.